Associations of HLA‐C*01:02 and HLA‐B*46:01 with regorafenib‐induced erythema multiforme in Japanese patients with metastatic colorectal cancer

por Fujita, Ken‐ichi, Matsumoto, Natsumi, Murase, Remi, Takeshima, Kosuke, Ishida, Hiroo, Kubota, Yutaro
Publicado 2023

Phylogenetic Relationships of Citrus and Its Relatives Based on matK Gene Sequences

por Penjor, Tshering, Yamamoto, Masashi, Uehara, Miki, Ide, Manami, Matsumoto, Natsumi, Matsumoto, Ryoji, Nagano, Yukio
Publicado 2013

Decreased Disposition of Anticancer Drugs Predominantly Eliminated via the Liver in Patients with Renal Failure

por Fujita, Ken-ichi, Matsumoto, Natsumi, Ishida, Hiroo, Kubota, Yutaro, Iwai, Shinichi, Shibanuma, Motoko, Kato, Yukio
Publicado 2019

Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study

por Nio, Yuta, Ishida, Hiroo, Matsumoto, Natsumi, Kusumoto, Sojiro, Kubota, Yutaro, Tsunoda, Takuya, Sasaki, Yasutsuna, Fujita, Ken-ichi
Publicado 2022

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer

por Arai, Jun, Otoyama, Yumi, Fujita, Ken-ichi, Goto, Kaku, Tojo, Masayuki, Katagiri, Atsushi, Nozawa, Hisako, Kubota, Yutaro, Takahashi, Takehiro, Ishida, Hiroo, Tsunoda, Takuya, Matsumoto, Natsumi, Ogawa, Keita, Nakagawa, Ryo, Muroyama, Ryosuke, Kato, Naoya, Yoshida, Hitoshi
Publicado 2022